Why Atea Pharmaceuticals Is Up 17% Today

·2-min read
Why Atea Pharmaceuticals Is Up 17% Today

Orally administered treatments of COVID-19 infections are coming into focus as vaccine stocks lose their luster.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting